GB/T 12279.2-2024

Active

Cardiovascular implants—Cardiac valve prostheses—Part 2: Surgically implanted heart valve substitutes

心血管植入器械 人工心脏瓣膜 第2部分:外科植入式人工心脏瓣膜

Standard Type
GBT
ICS
11.040.40
CCS
C45
Status
Active
Issue Date
2024-06-29
Implementation
2025-07-01
Centralized Committee
国家药监局
Issuing Authority
国家市场监督管理总局、 国家标准化管理委员会

Application Summary AI generated

This standard specifies the requirements, test methods, and labeling for surgically implanted heart valve substitutes used to replace diseased or damaged native heart valves. It is applied in the medical device industry for the design, manufacturing, and quality control of mechanical and bioprosthetic heart valves intended for surgical implantation in patients. The standard ensures safety and performance in clinical use, particularly during regulatory evaluation and pre-market testing.

Related Standards

Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.